$LPCN
Lipocine Inc.
XNAS•Health Care•Pharmaceutical Preparations
Lipocine Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is LPCN down today? It is at $1.53 (-1.33%), and our scanner flagged it 14 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LPCN spikes, and full due diligence on LPCN — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LPCN 14 times in the last 30 days. Create a free account to track $LPCN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how LPCN traded in the last session, Friday (last price and move above). Our scanner fired 3 unusual-volume and momentum alerts on LPCN on Friday, peaking at 11.9x its normal volume.
Likely catalystClinical / FDA update, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Nov 20, 2026 · yesterdayA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Patel Mahesh V. Officer | Bought (open market) | +25K 0.2% of company | added 13% | 211K | $40K at $1.60 | Nov 13, 26 |
Patel Mahesh V. Officer | Bought (open market) | +25K 0.2% of company | added 15% | 186K | $40K at $1.58 | Nov 12, 26 |
Higuchi John W. Director | Bought (open market) | +16K 0.1% of company | added 7.1% | 241K | $36K at $2.23 | Sep 30, 26 |
Higuchi John W. Director | Bought (open market) | +9K 0.08% of company | added 4.2% | 225K | $19K at $2.15 | Sep 29, 26 |
Higuchi John W. Director | Bought (open market) | +13K 0.1% of company | added 6.2% | 216K | $27K at $2.16 | Sep 28, 26 |
Higuchi John W. Director | Bought (open market) | +40K 0.4% of company | added 24% | 204K | $81K at $2.03 | Apr 7, 26 |
Patel Mahesh V. Officer | Bought (open market) | +25K 0.2% of company | added 18% | 161K | $51K at $2.03 | Apr 6, 26 |
Higuchi John W. Director | Bought (open market) | +123K 1.1% of company | added 100% | 164K | $252K at $2.05 | Apr 6, 26 |
Patel Mahesh V. Officer | Bought (open market) | +25K 0.2% of company | added 23% | 136K | $51K at $2.02 | Apr 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.



The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how LPCN traded in the last session, Friday (last price and move above). Our scanner fired 3 unusual-volume and momentum alerts on LPCN on Friday, peaking at 11.9x its normal volume.
LPCN last traded at $1.53, down 1.33% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The LPCN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LPCN 14 times in the last 30 days.
LPCN (Lipocine Inc.) trades on XNAS, with a market cap of about $16M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LPCN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LPCN discussion
Sign in to ask a question or join the discussion.